WINDTREE THERAPEUTICS INC /DE/ Earnings Per Share (Basic)
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Earnings Per Share (Basic) of -$1.08 per share for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic for the quarter ending 2025-09-30 was -$1.08.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic for the quarter ending 2025-06-30 was -$3.06.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic for the quarter ending 2025-03-31 was -$4.63, a 100.42% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic for the quarter ending 2024-12-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic for fiscal 2024 was -$104.35.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic for fiscal 2023 was -$4718.84.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic for fiscal 2022 was -$62.23.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic for fiscal 2021 was -$136.64.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -$1.08 10-Q · filed 2025-11-19 | -$2.78 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$4.46 10-Q · filed 2025-11-19 | -$0.15 derived: net income ÷ weighted average shares · filed 2025-11-19 | ||||
| 2025-06-30 | -$3.06 10-Q · filed 2025-08-19 | -$6.67 10-Q · filed 2025-08-19 | -$0.05 derived: net income ÷ weighted average shares · filed 2025-08-19 | -$0.07 derived: net income ÷ weighted average shares · filed 2025-11-19 | ||||
| 2025-03-31 | -$4.63 10-Q · filed 2025-05-15 | -$0.01 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$0.02 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$0.06 derived: net income ÷ weighted average shares · filed 2025-11-19 | ||||
| 2024-12-31 | $0.00 derived: net income ÷ weighted average shares · filed 2025-04-15 | -$0.04 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$0.22 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$104.35 10-K · filed 2025-04-15 | ||||
| 2024-09-30 | -$211.38 10-Q · filed 2025-11-19 | -$4.23 10-Q · filed 2024-11-26 | -$1079.04 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$431.89 10-Q · filed 2025-11-19 | -$8.64 10-Q · filed 2024-11-26 | -$1.65 derived: net income ÷ weighted average shares · filed 2025-11-19 | ||
| 2024-06-30 | -$1045.84 10-Q · filed 2025-08-19 | -$20.91 10-Q · filed 2024-08-19 | -$173.62 10-Q · filed 2025-08-19 | -$3.47 10-Q · filed 2024-08-19 | -$0.80 derived: net income ÷ weighted average shares · filed 2025-08-19 | -$1.74 derived: net income ÷ weighted average shares · filed 2025-08-19 | ||
| 2024-03-31 | $1099.37 10-Q · filed 2025-05-15 | $21.98 10-Q · filed 2024-05-15 | $0.39 derived: net income ÷ weighted average shares · filed 2025-05-15 | $0.07 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||||
| 2023-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2025-04-15 | -$1.13 derived: net income ÷ weighted average shares · filed 2025-04-15 | -$4718.84 10-K · filed 2025-04-15 | -$5.24 10-K · filed 2024-04-16 | ||||
| 2023-09-30 | -$15.47 10-Q · filed 2024-11-26 | -$0.86 10-Q · filed 2023-11-09 | -$80.95 10-Q · filed 2024-11-26 | -$4.50 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | -$29.47 10-Q · filed 2024-08-19 | -$1.64 10-Q · filed 2023-08-07 | -$78.76 10-Q · filed 2024-08-19 | -$4.36 10-Q · filed 2023-08-07 | ||||
| 2023-03-31 | -$85.65 10-Q · filed 2024-05-15 | -$4.76 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | -$62.23 10-K · filed 2024-04-16 | |||||||
| 2022-09-30 | -$6.51 10-Q · filed 2023-11-09 | -$0.13 10-Q · filed 2022-11-14 | -$49.94 10-Q · filed 2023-11-09 | -$1.00 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$29.68 10-Q · filed 2023-08-07 | -$0.59 10-Q · filed 2022-08-11 | -$44.28 10-Q · filed 2023-08-07 | -$0.87 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | -$14.36 10-Q · filed 2023-05-15 | -$0.29 10-Q · filed 2022-05-05 | ||||||
| 2021-12-31 | -$136.64 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | -$0.31 10-Q · filed 2022-11-14 | -$2.31 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$1.42 10-Q · filed 2022-08-11 | -$2.10 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | -$0.51 10-Q · filed 2022-05-05 | |||||||
| 2018-12-31 | -$3.24 10-K/A · filed 2019-04-23 | -$4.96 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$6.17 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$7.74 10-K/A · filed 2019-04-23 | ||||
| 2018-09-30 | -$1.04 10-K/A · filed 2019-04-23 | -$1.86 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$3.21 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$2.74 derived: net income ÷ weighted average shares · filed 2020-04-03 | ||||
| 2018-06-30 | -$0.81 10-K/A · filed 2019-04-23 | -$2.17 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$1.63 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$5.05 derived: net income ÷ weighted average shares · filed 2020-04-03 | ||||
| 2018-03-31 | -$1.40 10-K/A · filed 2019-04-23 | -$0.72 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$4.58 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$9.90 derived: net income ÷ weighted average shares · filed 2020-04-03 | ||||
| 2017-12-31 | $1.03 10-K/A · filed 2019-04-23 | -$3.32 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$10.29 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$24.14 10-K/A · filed 2019-04-23 | ||||
| 2017-09-30 | -$10.53 10-K/A · filed 2019-04-23 | -$24.21 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$48.56 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$13.28 derived: net income ÷ weighted average shares · filed 2019-04-23 | ||||
| 2017-06-30 | -$14.37 10-K/A · filed 2019-04-23 | -$40.99 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$8.30 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$7.75 derived: net income ÷ weighted average shares · filed 2019-04-23 | ||||
| 2017-03-31 | -$27.40 10-K/A · filed 2019-04-23 | -$4.22 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$4.73 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$5.93 derived: net income ÷ weighted average shares · filed 2019-04-23 | ||||
| 2016-12-31 | -$0.77 10-K · filed 2017-03-31 | -$1.77 derived: net income ÷ weighted average shares · filed 2018-04-17 | -$3.06 derived: net income ÷ weighted average shares · filed 2018-04-17 | -$4.74 10-K · filed 2017-03-31 | ||||
| 2016-09-30 | -$1.00 10-K · filed 2017-03-31 | -$2.29 derived: net income ÷ weighted average shares · filed 2017-11-14 | -$3.98 derived: net income ÷ weighted average shares · filed 2017-11-14 | |||||
| 2016-06-30 | -$1.29 10-K · filed 2017-03-31 | -$2.99 derived: net income ÷ weighted average shares · filed 2017-08-21 | ||||||
| 2016-03-31 | -$1.70 10-K · filed 2017-03-31 | |||||||
| 2015-12-31 | -$1.26 10-K · filed 2017-03-31 | -$7.98 10-K · filed 2017-03-31 | ||||||
| 2015-09-30 | -$2.80 10-K · filed 2017-03-31 | -$0.20 10-Q · filed 2015-11-05 | -$0.49 10-Q · filed 2015-11-05 | |||||
| 2015-06-30 | -$1.82 10-K · filed 2017-03-31 | -$0.13 10-Q · filed 2015-08-10 | -$0.27 10-Q · filed 2015-08-10 | |||||
| 2015-03-31 | -$1.96 10-K · filed 2017-03-31 | |||||||
| 2014-12-31 | -$1.68 10-K · filed 2016-03-29 | -$0.12 10-K · filed 2015-03-16 | -$7.28 10-K · filed 2016-03-29 | -$0.52 10-K · filed 2015-03-16 | ||||
| 2014-09-30 | -$1.82 10-K · filed 2016-03-29 | -$0.13 10-Q · filed 2014-11-07 | -$0.39 10-Q · filed 2015-11-05 | |||||
| 2014-06-30 | -$1.68 10-K · filed 2016-03-29 | -$0.12 10-Q · filed 2014-08-07 | -$0.26 10-Q · filed 2015-08-10 | |||||
| 2014-03-31 | -$1.96 10-K · filed 2016-03-29 | -$0.14 10-K · filed 2015-03-16 | ||||||
| 2013-12-31 | -$0.16 10-K · filed 2015-03-16 | -$0.82 10-K · filed 2015-03-16 | ||||||
| 2013-09-30 | -$0.22 10-K · filed 2015-03-16 | -$0.68 10-Q · filed 2014-11-07 | ||||||
| 2013-06-30 | -$0.18 10-K · filed 2015-03-16 | -$0.46 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | -$0.29 10-K · filed 2015-03-16 | |||||||
| 2012-12-31 | -$0.95 10-K · filed 2015-03-16 | |||||||
| 2012-09-30 | -$0.31 10-Q · filed 2013-11-12 | -$0.80 10-Q · filed 2013-11-12 | ||||||
| 2012-06-30 | -$0.16 10-Q · filed 2013-08-08 | -$0.49 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |